nicotine has been researched along with Systemic Inflammatory Response Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, DL; Petersen, SR; Roberts, JL; Romanovsky, AA; Steiner, AA | 1 |
| Miles, MP | 1 |
| Hu, S; Lv, Y; Sheng, Z; Song, Q; Zhou, G; Zou, X | 1 |
3 other study(ies) available for nicotine and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Nicotine administration and withdrawal affect survival in systemic inflammation models.
Topics: Animals; Body Temperature; Cecum; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Infusion Pumps, Implantable; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Sepsis; Substance Withdrawal Syndrome; Systemic Inflammatory Response Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
How do we solve the puzzle of unintended consequences of inflammation? Systematically.
Topics: Animals; Biomedical Research; Body Temperature; Cecum; Disease Models, Animal; Disease Progression; Humans; Lipopolysaccharides; Nicotine; Nicotinic Agonists; Research Design; Sepsis; Substance Withdrawal Syndrome; Systemic Inflammatory Response Syndrome; Tobacco Use Disorder | 2008 |
Carbachol alleviates rat cytokine release and organ dysfunction induced by lipopolysaccharide.
Topics: Animals; Carbachol; Cells, Cultured; Cholinergic Agonists; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Lipopolysaccharides; Macrophages, Peritoneal; Male; Microscopy, Confocal; Multiple Organ Failure; Nicotine; Rats; Rats, Wistar; Survival Rate; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2011 |